ClinicalTrials.gg
Not yet recruitingNCT07939438Updated Nov 16, 2026

Postoperative Stenting After Flexible Ureteroscopy in Children With Upper Urinary Tract Stones

An interventional study of Flexible and Navigable Suction Ureteral Access Sheath (FANS-UAS) in Urolithiasis, Kidney Calculi and Ureteral Calculi, sponsored by Misr University for Science and Technology. Not yet recruiting at 1 site in Egypt. Open to participants aged 6 Years to 16 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Misr University for Science and Technology · Not applicable, Interventional, and Treatment

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
6 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 25 studies in Urolithiasis with a site in Egypt — 7 open to participants now, 10 under way, 1 of them phase 3. Urolithiasis · Egypt.

Planned enrollment
20th of 22
50 · median 145
Started
2026
with 4 others
No phase
16 of 25
4 open now
Registered
25th of 25
by date
Lead sponsor
1 of 25
Misr University for Science and Technology

Among the 25 studies in Urolithiasis with a site in Egypt, this one is the 20th largest by planned enrollment of the 22 interventional ones that give a count, is one of 5 that started in 2026, is one of 16 with no phase, and was the 25th registered.

Urolithiasis

255 studies on the registry are indexed under Urolithiasis; 68 are open to participants now.

Browse Urolithiasis studies →

Open to participants now

7 of the 25 studies in Urolithiasis with a site in Egypt are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 38 Urolithiasis studies recruiting now, 18 (47%) set no upper age limit and 12 (32%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 6 Years to 16 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Urolithiasis with a site in Egypt, or all of them as a file.
02

Study summary

This study aims to evaluate whether postoperative double-J ureteral stent placement can be safely avoided in children undergoing flexible ureteroscopy using a flexible and navigable suction ureteral access sheath (FANS-UAS) for upper urinary tract stones.

The study will include 50 children aged 6-16 years with upper urinary tract stones measuring 1-2 cm who undergo flexible ureteroscopy at Ain Shams University Hospitals.

During the procedure, a suction-assisted ureteral access sheath will be used to facilitate stone fragmentation and removal. The decision to place a postoperative ureteral stent will be based on intraoperative findings and the surgeon's assessment.

The study will assess the need for postoperative stenting, stone clearance, postoperative pain, fever, and other procedure-related complications to determine whether flexible and navigable suction ureteral access sheath (FANS-UAS) can reduce unnecessary stent placement while maintaining procedural safety and effectiveness.

03

Conditions studied

  • Urolithiasis
  • Kidney Calculi
  • Ureteral Calculi

Keywords

  • Pediatric Urolithiasis
  • Retrograde Intrarenal Surgery
  • Flexible Ureteroscopy
  • Flexible and Navigable Suction Ureteral Access Sheath
  • Postoperative Ureteral Stenting
  • Stone-Free Rate
  • Double-J Ureteral Stent
04

Who can participate

Ages eligible
6 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 6 to 16 years of either sex.
  • Patients with upper urinary tract stones measuring 1-2 cm.

Exclusion criteria

Exclusion Criteria:

  • Patients with untreated or active urinary tract infection (UTI).
  • Patients with urinary tract stricture or pelvi-ureteric junction obstruction (PUJO).
  • Patients with renal stones located in a calyceal diverticulum.
  • Patients with a solitary kidney.
  • Patients unfit for anesthesia.
  • Patients in whom insertion of the navigable suction ureteral access sheath is unsuccessful.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    FANS-UAS-Assisted Flexible Ureteroscopy

    All participants will undergo retrograde intrarenal surgery (RIRS) using flexible ureteroscopy assisted by a flexible and navigable suction ureteral access sheath (FANS-UAS) for the treatment of upper urinary tract stones. Laser lithotripsy will be performed using a holmium:YAG laser, with suction-assisted evacuation of stone fragments. The decision to place a postoperative double-J ureteral stent will be based on intraoperative findings, including residual stones, ureteral wall injury, bleeding, operative time, and surgeon discretion. Participants will undergo postoperative follow-up for one month.

    Device: Flexible and Navigable Suction Ureteral Access Sheath (FANS-UAS)

Interventions

  • DeviceFlexible and Navigable Suction Ureteral Access Sheath (FANS-UAS)

    A 9.5 Fr suction ureteral access sheath (ClearPetra) will be inserted into the ureter during retrograde intrarenal surgery (RIRS). The sheath tip will be positioned in the renal pelvis or calyces near the stone and connected to a suction device. Negative pressure will be adjusted intraoperatively to facilitate irrigation fluid drainage, maintain visualization, and evacuate stone fragments during holmium:YAG laser lithotripsy. The procedure will be performed using a 7.5 Fr flexible ureteroscope.

06

What researchers measure

Primary outcomes

  1. Successful Avoidance of Postoperative Double-J Ureteral Stenting

    Proportion of patients in whom postoperative double-J ureteral stent placement is avoided following flexible ureteroscopy using FANS-UAS without requiring an additional postoperative intervention during follow-up.

    Time frame: Up to 1 month after surgery

Secondary outcomes

  1. Stone-Free Rate Following Flexible Ureteroscopy

    Proportion of patients without residual stone fragments larger than 4 mm, assessed using kidney, ureter, and bladder (KUB) radiography and non-contrast computed tomography of the urinary tract (NCCTUT).

    Time frame: Up to 1 month after surgery

  2. Postoperative Pain Score

    Postoperative pain severity assessed using a visual analogue scale (VAS) ranging from 1 to 10, with higher scores indicating greater pain intensity.

    Time frame: Up to 1 month after surgery

  3. Incidence of Postoperative Fever

    Proportion of patients experiencing postoperative fever following FANS-UAS-assisted flexible ureteroscopy.

    Time frame: Up to 1 month after surgery

  4. Operative Time

    Duration of the surgical procedure, measured in minutes.

    Time frame: During surgery

  5. Incidence of Ureteric Stricture

    Proportion of patients diagnosed with ureteric stricture during postoperative follow-up.

    Time frame: Up to 1 month after surgery

  6. Incidence of Calyceal Rupture

    Proportion of patients experiencing calyceal rupture during the surgical procedure.

    Time frame: During surgery

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for May 2027, 6 months later.

Of 87 non-industry interventional studies with no phase under Urolithiasis, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 40. This study's planned 6 months is below that.

Counting every sponsor, half of 97 studies reached it within 19 months; a quarter within 11 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 16, 2026
StartEst.
Nov 30, 2026
Primary completionEst.
May 30, 2027
CompletionEst.
May 30, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07939438
Lead sponsor
Misr University for Science and Technology
Responsible party
Abdelrhman Mansour Ali Ali Elbarbary (Resident of Urology, Misr University for Science and Technology) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 30, 2026 (estimated)
Primary completion
May 30, 2027 (estimated)
Completion
May 30, 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Abdelrhman M Elbarbary, MBBCh
Contact
abdomedo6300@gmail.com
0 10 23839948 ext. +2

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion